“The introduction of hydrophilic antimicrobial intermittent catheters has aided individuals in easily performing catheterization at homes which causes minimal pain and ureteral injuries while insertion. Such benefits has further helped in boosting the growth of intermittent catheters market by creating ample opportunities in the market. Moreover, developing countries such as India, China and Brazil among others will represent lucrative destination owing to the remarkable growth and rise in the disposable income.”
Intermittent catheter is a type of urological catheter, which is utilized to drain urine from the urinary bladder when individuals are not able to perform it naturally. These catheters are made from PVC or vinyl, latex rubber, and silicone materials, and are intended for one-time use. The major users of intermittent catheters are individuals with spinal cord injury or people suffering from urinary incontinence. The global intermittent catheters market was valued at $1,655.5 million in 2016, and is expected to reach $2,950.7 million by 2023 at a CAGR of 8.7% during the forecast period.
The key factors driving the growth of intermittent catheters market are rise in urinary incontinence cases and increase in geriatric population globally. However, price competition at the domestic level and lack of awareness about the benefits of intermittent catheters hinder the market growth. On the contrary, launch of novel catheters such as the hydrophilic antimicrobial intermittent catheters is anticipated to create lucrative opportunities for the market expansion.
The global intermittent catheters market is segmented based on product, indication, category, end user, and region. On the basis of product, the market is bifurcated into uncoated intermittent catheters and coated intermittent catheters. Coated intermittent catheters are further classified into antimicrobial, hydrophilic, and others. By indication, the market is categorized into urinary incontinence, spinal cord injuries, general surgery, and others. According to category, it is divided into female length catheter, male length catheters, and kid length catheter. Depending on end user, it is fragmented into hospitals, ambulatory surgical centers, and medical research centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Based on product, coated intermittent catheters is projected to be one of the most lucrative segments, owing to the introduction of antimicrobial intermittent catheters. These catheters aid in minimizing infections caused during the catheterization process. For instance, For instance, the Magic 3 intermittent antibacterial catheter by C.R. Bard is coated with nitrofurazone, which is an antibacterial agent that is applied on the outer surface of the catheter, and has been proven to be effective against a variety of pathogens, which cause urinary tract infections.
Based on indication, the urinary incontinence segment dominated the market in 2016, owing to increase in urinary incontinence cases globally. For instance, 25 million adults in the U.S. suffer from urinary incontinence every year, among which 75-80% are women. Moreover, about 200 million individuals are affected by urinary incontinence globally. Thus, rise in prevalence of urinary incontinence is expected to augment the market growth.